Objective: To analyze the effect of ancylostomiasis control in 6 demonstration plots of parasitic disease comprehensive control, so as to provide the evidence for formulating the prevention and control measures of ancylostomiasis in the future.
Methods: According to the drugs and deworming schemes, the 6 demonstration plots (counties) were divided into 4 groups, namely A1 (Tunchang in Hainan Province and Danling in Sichuan Province), A2 (Tongcheng in Anhui Province and Yueyang in Hunan Province), B (Guixi in Jiangxi Province), C (Rongxian in Guangxi Zhuang Autonomous Region) groups. The infection rates of hookworm before and after the comprehensive control in the 6 counties were compared, and the costs of reducing one infected case and 1% of infection rate were calculated.
Results: The infection rates of hookworm in Group A1, A2, B and C were reduced by 73.36%, 93.67%, 75.95% and 59.04%, respectively. The costs of reducing one infected person were 17.33, 30.06, 11.50, 73.34, 31.28 Yuan and 27.34 Yuan in Tunchang, Danling, Tongcheng, Guixi, Rongxian and Yueyang, respectively, while those of reducing 1% of the infection rate were 38 206.93, 28 577.55, 59 716.30, 295 074.91, 110 729.47 Yuan and 202 328.80 Yuan, respectively.
Conclusions: The effect of comprehensive control of ancylostomiasis in demonstration plots is remarkable. Under the same control measure, the higher the infection rates are, the less the cost will be for reducing one infected person or infection rate by 1%, and when the infection rate is below 10%, the control cost is high.
Download full-text PDF |
Source |
---|
BMC Pediatr
December 2024
Department of Nursing, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.
Background: Birth asphyxia is a critical condition caused by an insufficient oxygen supply during delivery, and it poses a major threat to the health of newborns. The present meta-analysis aimed to estimate the prevalence of birth asphyxia among neonates and identify its risk factors in China.
Methods: PubMed, EMBASE, Scopus, Web of Science, the China Academic Journals (CNKI), the Chinese Biomedical Literature (CBM), the China Science and Technology Journal Database (VIP), and the WanFang database were searched for related publications.
Eur J Radiol
December 2024
Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China; Shanghai Institute of Medical Imaging, Shanghai, China. Electronic address:
Purpose: Microvascular invasion (MVI) serves as a significant predictor of poor prognosis in intrahepatic cholangiocarcinoma (ICC). This study aims to establish a comprehensive model utilizing MR radiomics for preoperative MVI status stratification and outcome prediction in ICC patients.
Materials And Methods: A total of 249 ICC patients were randomly assigned to training and validation cohorts (174:75), along with a time-independent test cohort consisting of 47 ICC patients.
J Biomol Struct Dyn
December 2024
School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Bhubaneswar, India.
Glimepiride (GLM) is one of the potential antidiabetic drugs used in clinics for a long time. It is currently used in combination with metformin along with other drugs, but has shown various complications in patients from long-term use. Thus, the hypothesis is to use a lower dose of GLM with a non-toxic class of flavonoid, naringin (NARN), for better therapy with minimal side-effects.
View Article and Find Full Text PDFOrthod Craniofac Res
December 2024
Department of Orthodontics & Dentofacial Orthopaedics, Manav Rachna Dental College, Faridabad, India.
Objective: The study compares and evaluates planned virtual outcomes with actual post-treatment outcomes to assess the accuracy and predictability of clinical results during presurgical infant orthopaedics (PSIO) with AlignerNAM in infants with unilateral cleft lip and palate.
Setting: Institutional study.
Participants: 14 UCLP patients.
Unlabelled: Diabetic macular edema (DME) is a leading cause of visual impairment and blindness among diabetic patients, its prevalence is continuing to increase worldwide. Faricimab, a bispecific antibody, represents a new generation of treatments for DME.
Purpose: This study presents an indirect comparison of the effectiveness and safety of faricimab versus other treatment options for DME.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!